We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Life Science REIT (LABS) ORD GBP0.01

Sell:38.30p Buy:38.70p 0 Change: 1.00p (2.52%)
Market closed Prices as at close on 21 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:38.30p
Buy:38.70p
Change: 1.00p (2.52%)
Market closed Prices as at close on 21 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:38.30p
Buy:38.70p
Change: 1.00p (2.52%)
Market closed Prices as at close on 21 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
40.40p
Trade high:
40.40p
Year high:
66.80p
Estimated NAV:
76.22
Previous close:
39.70p
Trade low:
38.00p
Year low:
31.30p
Premium/Discount:
-47.91%
Previous:
0.00p (0.00%)
Previous:
0.00p
Volume:
414,569
Dividend yield:
5.17%
Currency:
GBX
Data delayed by at least 15 minutes.

Price

  • Net Asset Value (NAV)
LIFE SCIENCE performance chart

Premium/Discount

LIFE SCIENCE performance chart
Full interactive share price and premium / discount charts

Performance

1 week 1W 5.48% 1 year 1Y 40.39%
1 month 1M 1.79% 2 years 2Y 47.09%
3 months 3M 16.08% 3 years 3Y 60.5%
6 months 6M 7.3% 5 years 5Y n/a

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: No benchmark
Annual management charge: n/a
Performance fee: No
Ongoing charge: 1.10%
Dividend yield: 5.17%
Dividend frequency: Semi-Annually
Total assets: £376m
Gross gearing: 40%
Market capitalisation:Market cap.: £139m
Shares in issue: 350.00 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB00BP5X4Q29

Recent dividends paid or declared by Life Science REIT:

Type Ex-div date Payment date Amount
Interim 03/10/2024 31/10/2024 1.00p
2nd interim 04/04/2024 13/05/2024 1.00p
Interim 28/09/2023 31/10/2023 1.00p
2nd interim 13/04/2023 15/05/2023 3.00p
Interim 29/09/2022 31/10/2022 1.00p

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual Life Science REIT dividends:

Financial
year end
Dividend
yield
Dividend
cover
Total dividend
paid
31/12/2023 3.20% 0.95 2.00p
31/12/2022 5.50% 0.17 4.00p
31/12/2021 n/a n/a n/a

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents



Objective

The Company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the UK which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. Life science is the branch of sciences concerned with the study of living organisms. This encompasses the study of the breadth of life processes, and the structure and behaviour of living things. Companies operating in the life science sector include, but are not limited to, those involved in the innovation, development and/or production of assets directly or indirectly for human health purposes.

NET ASSET VALUE (NAV)

Estimated NAV: 76.22p
Latest actual NAV: n/a
Latest actual NAV date: n/a
Premium/Discount: -47.91%
12m average Premium/Discount: -47.03%
NAV frequency: Semi-Annually
Security Weight
Investment Property 134.73%

Top 10 sectors currently unavailable.

Top 10 countries currently unavailable.

Key Dates

Launch date: 18 November 2021
Financial year end: December
Next AGM: May 2025
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.